MIT working on hydrogel tech for battlefield wounds; BioDelivery Sciences and Endo discuss candidate with FDA;

> MIT researcher Brad Olsen, along with two co-workers, is working to develop an injectable hydrogel for use on battlefield wounds. Story

> BioDelivery Sciences International ($BDSI) and Endo Pharmaceuticals ($ENDP) met with the FDA on July 15 to discuss BEMA Buprenorphine for severe pain management. Release